Wyeth

...member Patricia Ferrieri, a professor at the University of Minnesota Medical Center. New York-based Pfizer acquired Prevnar from Wyeth, as part of a $68 billion buyout that closed last month. Prevnar has been on the market for more than...

In this article: Pfizer, Food and Drug Administration, GlaxoSmithKline, Merck, Meningitis, European Union, and U.S.

...<PFE.N> newer version of the Prevnar pneumococcus vaccine, the most important experimental product the company acquired from Wyeth, won support from U.S. advisers on Wednesday. A Food and Drug Administration advisory committee voted 10-1...

In this article: Pfizer, Food and Drug Administration, US, Streptococcus pneumoniae, Meningitis, and New York Stock Exchange

...with universal flu and Alzheimer's vaccines, says research head Dr. Paul Stoffels. Even Pfizer Inc.'s $68 billion acquisition of Wyeth in October was partly about getting its vaccine expertise, now being put to work against Alzheimer's.

In this article: FLU, Alzheimer's, GlaxoSmithKline, AIDS, Johnson & Johnson, U.S., Cervical cancer, Meningitis, and Rotavirus

...streptococcus pneumoniae, or pneumococcus, that cause an array of illnesses. The vaccine was the most important product in the pipeline of Wyeth, which Pfizer recently acquired. The Food and Drug Administration is weighing whether to approve...

In this article: Pfizer, Food and Drug Administration, United States, Europe, Streptococcus pneumoniae, European Medicines Agency, and World Health Organization

By Ransdell Pierson and Bill Berkrot Pfizer Inc CEO Jeffrey Kindler said the drugmaker is integrating its Wyeth purchase far faster than previous big acquisitions, and it will no longer be overly dependent on one or two blockbuster...

In this article: Pfizer, Lipitor, Revenue, Alzheimer's disease, United States, and Pharmacia

Latest local and international economic news, market & financial reports Pfizer to close Wyeth's former research facility in South Brunswick, among others HENNY RAY ABRAMS/AFP/Getty ImagesThis Feb. 7, 2000 file photo shows pharmaceutical...

In this article: Pfizer, Alzheimer's disease, Groton, New Jersey, New York, and Connecticut

Pfizer Inc., which just acquired fellow drugmaker Wyeth, is closing six of the two companies' research sites and keeping open 14 others. Two Cambridge, Mass., sites will operate as one. Following is a list of the sites: Former Wyeth sites...

In this article: Pfizer Inc, Cambridge, Massachusetts, and Pennsylvania

...position as the world's biggest drugmaker with its $68 billion purchase of drug and vaccine maker Wyeth on Oct. 15, diversifying overnight by adding Wyeth's biotech drugs and consumer and animal health divisions. The two executives heading...

In this article: Pfizer Inc., Cancer, Alzheimer's disease, New Jersey, Chesterfield, New York, and Monsanto Co

...and business opportunities to find the one that is right for you. Pfizer closing six research plants, cutting jobs after buying Wyeth By Linda A. Johnson, Associated Press TRENTON, N.J. The world's biggest drugmaker said Monday...

In this article: Pfizer, New Jersey, New York, Pharmacia, Cancer, Alzheimer's disease, and USA Today

In this article: Moody's, Pfizer Inc., and NEW YORK